Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
1 study found for:    23401447 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Terminated Elesclomol (STA-4783) With Paclitaxel Versus Paclitaxel Alone in Melanoma
Condition: Melanoma
Interventions: Drug: Elesclomol (STA-4783);   Drug: Paclitaxel

Study has passed its completion date and status has not been verified in more than two years.